Published in Br J Surg on August 01, 1995
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg (1996) 1.51
Liver transplantation for acute liver failure at 11-week gestation with successful maternal and fetal outcome. Case Rep Transplant (2012) 0.80
Acute Liver Failure Occurring during the First Trimester of Pregnancy Successfully Treated with Living Donor Liver Transplantation. Case Rep Transplant (2013) 0.75
Liver Transplantation during Pregnancy for Acute Liver Failure due to HBV Infection: A Case Report. Case Rep Obstet Gynecol (2013) 0.75
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
Management of the Mirizzi syndrome and the surgical implications of cholecystcholedochal fistula. Br J Surg (1990) 2.89
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83
Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73
Spontaneous rupture of hepatocellular carcinoma. Br J Surg (1996) 1.68
Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg (1990) 1.63
Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg (1998) 1.63
Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol (2000) 1.62
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg (2007) 1.56
The arterioportal fistula syndrome: clinicopathologic features, diagnosis, and therapy. Gastroenterology (1997) 1.55
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52
Side-to-side cavo-cavostomy: a useful aid in "complicated" piggy-back liver transplantation. Transpl Int (1993) 1.48
Systematic assessment of massive bleeding of the lower part of the gastrointestinal tract. Surg Gynecol Obstet (1992) 1.45
Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg (1998) 1.42
Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth (2003) 1.42
Resection of phaeochromocytoma extending into the right atrium in a patient with multiple endocrine neoplasia type 2A. Hong Kong Med J (2005) 1.42
Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
Pancreatic pleural effusion: an indication for emergency distal pancreatectomy and Roux-en-Y pancreatico-jejunostomy. J Pediatr Surg (1994) 1.38
Early decision for conversion of laparoscopic to open cholecystectomy for treatment of acute cholecystitis. Am J Surg (1997) 1.36
Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg (1994) 1.34
Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer (1995) 1.33
Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology (1990) 1.31
Spontaneous rupture of hepatocellular carcinoma and vascular injury. Arch Surg (2001) 1.30
Factors affecting conversion of laparoscopic cholecystectomy to open surgery. Arch Surg (1996) 1.28
Pyogenic liver abscess. An audit of experience over the past decade. Arch Surg (1996) 1.27
Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut (1989) 1.26
Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer (1992) 1.25
Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer (1998) 1.24
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol (2000) 1.24
Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer (1994) 1.23
Biliary complications during liver resection. World J Surg (2001) 1.23
Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg (1999) 1.22
Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization. Br J Surg (1998) 1.22
Acute torsion of the gall bladder in the aged: a re-emphasis on clinical diagnosis. Aust N Z J Surg (1982) 1.21
Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg (1998) 1.21
Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg (1998) 1.20
Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc (1999) 1.19
Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes. Br J Cancer (2000) 1.16
Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg (2001) 1.15
Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am J Surg (2001) 1.15
Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods (2005) 1.14
Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis. Antimicrob Agents Chemother (1985) 1.13
Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg (2009) 1.13
Emergency surgery for severe acute cholangitis. The high-risk patients. Ann Surg (1990) 1.12
Intrahepatic cholangiocarcinoma. World J Surg (1997) 1.11
A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections. J Antimicrob Chemother (1989) 1.11
Spontaneous ruptured hepatocellular carcinoma. An appraisal of surgical treatment. Ann Surg (1989) 1.11
Tolerance of the liver to intermittent pringle maneuver in hepatectomy for liver tumors. Arch Surg (1999) 1.11
The changing epidemiology of recurrent pyogenic cholangitis. Hong Kong Med J (1997) 1.10
Extending the limit on the size of adult recipient in living donor liver transplantation using extended right lobe graft. Transplantation (1997) 1.09
Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma. Br J Surg (2006) 1.08
The role of hepatic arterial embolization in the treatment of spontaneous rupture of hepatocellular carcinoma. Clin Radiol (1998) 1.08
Negative findings at appendectomy. Am J Surg (1984) 1.08
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma. Int J Cancer (1998) 1.08
Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation (1996) 1.07
Better survival in female patients with hepatocellular carcinoma. Possible causes from a pathologic approach. Cancer (1995) 1.06
Pancreatic insulinomas. A 15-year experience. Arch Surg (1997) 1.05
Right-lobe live donor liver transplantation improves survival of patients with acute liver failure. Br J Surg (2002) 1.05
Gallbladder cancer presenting with acute cholecystitis: a population-based study. Surg Endosc (2005) 1.04
Malignant insulinoma with hepatoid differentiation: a unique case with alpha-fetoprotein production. Endocr Pathol (2001) 1.03
Intra-abdominal follicular dendritic cell tumour: a rare tumour in need of recognition. Histopathology (1998) 1.03
Expression of P-glycoprotein in hepatocellular carcinoma. A determinant of chemotherapy response. Am J Clin Pathol (2000) 1.03
Results of surgical resection for hepatocellular carcinoma. Hepatogastroenterology (1990) 1.03
The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence. Br J Cancer (2007) 1.02
Identification of liver-intestine cadherin in hepatocellular carcinoma--a potential disease marker. Biochem Biophys Res Commun (2003) 1.02
Acute appendicitis in the elderly. Surg Gynecol Obstet (1985) 1.01
A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg (2001) 1.01
Treatment of inoperable hepatocellular carcinoma by transcatheter arterial chemoembolization using an emulsion of cisplatin in iodized oil and gelfoam. Clin Radiol (1993) 1.01
Value of intra-arterial calcium stimulated venous sampling for regionalization of pancreatic insulinomas. Surgery (2000) 1.01
Prediction of postoperative pulmonary complications in oesophagogastric cancer surgery. Br J Surg (1987) 1.00
Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut (2002) 1.00
Nonresectional therapies for hepatocellular carcinoma. Am J Surg (1997) 0.99